Consistently, inhibition of AKR1C2 sensitized melanoma cells to ferroptosis and the genetic inhibition of BRD4 enhanced the ferroptosis induced by RSL3 suggesting that BET inhibitors sensitize melanoma cells to ferroptosis. This evidence concerns the gene AKR1C2 and melanoma.